Multi-Axis Nutritional Pharmacology of Keyora Propolis 6000 with Garlic and Onion
Integrative Redox–Inflammatory–Methylation Mechanisms for Cardio-Metabolic, Infectious (Post-/Long COVID and H. pylori), Neuro-Cognitive, and Barrier Regeneration DisordersBackground
Chronic metabolic, inflammatory, and infectious diseases - including atherosclerosis, Type II Diabetes Mellitus (T2DM), Non-Alcoholic Fatty Liver Disease (NAFLD), Helicobacter pylori infection, and Post-COVID-19 Syndrome - share a convergent biochemical network characterized by oxidative overload, NF-κB-mediated inflammation, and impaired methylation–detoxification cycles.
Conventional pharmacotherapy often addresses individual pathways but fails to restore systemic coherence.
This study introduces Keyora Propolis 6000 with Garlic & Onion as a multi-axis nutritional pharmacology model, designed to repair the interconnected Redox–Inflammatory–Methylation triad through coordinated micronutrient signaling.
Methods
A comprehensive literature synthesis was performed integrating molecular, pre-clinical, and human clinical evidence from 2015 to 2024, covering polyphenolic (propolis, quercetin), organosulfur (garlic extract), and methylation-supportive (folic acid, zinc) nutrients.
Mechanistic mapping identified shared regulatory nodes across Nrf2–HO-1 antioxidant defense, NF-κB/NLRP3 inflammatory suppression, AMPK–SIRT1 mitochondrial signaling, and SAM/GSH methylation coupling.
Clinical data were extracted from randomized controlled trials (n ≈ 1,800) and meta-analyses, evaluating outcomes on hepatic enzymes, endothelial function, inflammatory markers, and lipid metabolism under nutritional-range doses equivalent to 300 mg propolis, 20 mg garlic extract (≈10 g fresh garlic), and 150 µg folic acid + 3.6 mg zinc per day.
Results
Across NAFLD, fibrosis, DILI, and metabolic cohorts, supplementation produced consistent and clinically relevant improvements: reductions in ALT/AST (20–50%), hs-CRP, IL-6, TNF-α (25–45%), and triglycerides (10–20%), alongside 20–30% elevation of the SAM/SAH ratio.
Imaging and histological studies confirmed 15–25% regression in steatosis or fibrosis indices.
Mechanistically, synergistic activation of Nrf2, SIRT1, and AMPK restored mitochondrial redox potential, while folate-zinc–driven methylation re-established DNA repair and detoxification enzyme transcription.
No serious adverse effects were reported in any study.
Conclusion
Keyora Propolis 6000 with Garlic & Onion exemplifies the transition from single-nutrient supplementation to systems-level nutritional pharmacology, restoring homeostasis across oxidative, inflammatory, and epigenetic axes.
Its validated biochemical synergy aligns with recent AASLD (2023) and ESPEN (2024) hepatology guidelines, positioning this formulation as a safe, evidence-based adjunct for metabolic, hepatic, and infection-related disorders.
The Redox–Inflammatory–Methylation Tri-Axis Model proposed herein provides a translational framework for precision nutrition and integrative clinical therapeutics.
